AnGes MG Inc.

10/18/2023 | Press release | Distributed by Public on 10/18/2023 00:35

Notice Regarding the Start of Administration of NF-κB Decoy Oligo DNA for the Treatment of Chronic Intervertebral Disc Lumbago in a Phase II Clinical Trial in Japan